ES8105263A1 - Un procedimiento para la preparacion de fenetanolaminas - Google Patents

Un procedimiento para la preparacion de fenetanolaminas

Info

Publication number
ES8105263A1
ES8105263A1 ES490211A ES490211A ES8105263A1 ES 8105263 A1 ES8105263 A1 ES 8105263A1 ES 490211 A ES490211 A ES 490211A ES 490211 A ES490211 A ES 490211A ES 8105263 A1 ES8105263 A1 ES 8105263A1
Authority
ES
Spain
Prior art keywords
hydrogen
formulations
preparation
optically active
fluorine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490211A
Other languages
English (en)
Other versions
ES490211A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8105263A1 publication Critical patent/ES8105263A1/es
Publication of ES490211A0 publication Critical patent/ES490211A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE FENETANOLAMINAS. CONSISTE EN SOMETER A REACCION DE REDUCCION A UN COMPUESTO DE FORMULA GENERAL (I), DONDE R1 ES HIDROGENO O FLUOR, R2 ES HIDROGENO O HIDROXI, R3 ES HIDROGENO, HIDROXI, FLUOR, AMINOCARBONILO, METILAMINOCARBONILO, METOXICARBONILO O ACETOXI; C* Y C** SON ATOMOS DE CARBONO ASIMETRICOS, M ES HIDROGENO O UN GRUPO PROTECTOR. SE OBTIENE UN COMPUESTO (II) CUANDO M NO ES HIDROGENO; SE EFECTUA A CONTINUACION LA SEPARACION DEL GRUPO PROTECTOR POR HIDROLISIS. *FORMULA* ACTIVIDAD SIMPATICOMIMETICA Y ESTIMULANTE CARDIACO.
ES490211A 1978-07-03 1980-04-01 Un procedimiento para la preparacion de fenetanolaminas Granted ES490211A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92166778A 1978-07-03 1978-07-03

Publications (2)

Publication Number Publication Date
ES8105263A1 true ES8105263A1 (es) 1981-05-16
ES490211A0 ES490211A0 (es) 1981-05-16

Family

ID=25445784

Family Applications (4)

Application Number Title Priority Date Filing Date
ES482154A Expired ES482154A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de fenetanolaminas.
ES490213A Granted ES490213A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de fenetanolaminas
ES490212A Granted ES490212A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de fenetanolaminas
ES490211A Granted ES490211A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de fenetanolaminas

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES482154A Expired ES482154A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de fenetanolaminas.
ES490213A Granted ES490213A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de fenetanolaminas
ES490212A Granted ES490212A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de fenetanolaminas

Country Status (25)

Country Link
EP (1) EP0007205A1 (es)
JP (1) JPS559098A (es)
AR (2) AR221884A1 (es)
AT (1) ATA463779A (es)
AU (1) AU4849079A (es)
BE (1) BE877391A (es)
BG (4) BG31491A3 (es)
CA (1) CA1145766A (es)
CS (1) CS225850B2 (es)
DD (1) DD145265A5 (es)
DK (1) DK269079A (es)
ES (4) ES482154A1 (es)
FI (1) FI792079A7 (es)
FR (1) FR2430408A1 (es)
GB (1) GB2029407A (es)
GR (1) GR72939B (es)
IL (1) IL57673A0 (es)
LU (1) LU81455A1 (es)
NZ (1) NZ190860A (es)
PH (1) PH15040A (es)
PL (3) PL117514B1 (es)
PT (1) PT69841A (es)
RO (1) RO77729A (es)
SU (1) SU936804A3 (es)
ZA (1) ZA793298B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
IL57672A (en) * 1978-07-03 1983-03-31 Lilly Co Eli Phenethanolamines,their preparation and pharmaceutical compositions containing the same
JPS57116300A (en) * 1981-01-12 1982-07-20 Fuji Photo Film Co Ltd Noise elimination in radiation image recording reproduction
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
US4690951A (en) * 1983-01-31 1987-09-01 Eli Lilly And Company Growth promotion
US5643967A (en) * 1983-01-31 1997-07-01 Eli Lilly And Company Growth promotion
US4562206A (en) * 1983-12-23 1985-12-31 Key Pharmaceuticals, Inc. Orally effective inotropic compounds
IT1204416B (it) * 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
AU7863394A (en) * 1993-10-20 1995-05-08 Tokyo Tanabe Company Limited Novel arylethanolamino(aryl)propanol compound
WO2002020821A2 (en) * 2000-09-08 2002-03-14 Dsm N.V. Process for the preparation of enantiomerically enriched amines
EP1672985A1 (en) * 2003-10-07 2006-06-28 Eli Lilly And Company Liquid formulations of ractopamine
WO2007143336A2 (en) * 2006-05-30 2007-12-13 Stirling Products Limited Use of ractopamine enantiomers
US20070282010A1 (en) 2006-05-30 2007-12-06 Bridge Pharma, Inc. Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals
US7723392B2 (en) 2007-12-03 2010-05-25 Bridge Pharma, Inc. Use of RR/SR-ractopamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894396C (de) * 1944-05-21 1953-10-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von 1-(o-, m- oder p-Oxyphenyl)-1-oxy-2-aralkylamino-aethanen
DE1182245B (de) * 1961-01-23 1964-11-26 Philips Nv Verfahren zur Herstellung eines uterospasmolytisch wirksamen linksdrehenden 1-(4'-Hy-droxyphenyl)-2-(1"-methyl-3"phenylpropylamino)-propanols
DE1543918A1 (de) * 1966-01-28 1970-01-08 Troponwerke Dinklage & Co 1-[m-Hydroxyphenyl]-2-[1-methyl-3-phenylpropyl-(1)-amino]-aethanol-(1) und Verfahren zu dessen Herstellung
NL6610530A (es) * 1966-07-27 1968-01-29
DE2044573A1 (en) * 1970-09-09 1972-03-23 Troponwerke Dinklage & Co, 5000 Köln-Mülheim 1-(hydroxyphenyl)-2-(1-phenyl-2-methylpropyl or 4-methylpentyl - -(2)-amino)-ethanols and their salts - betasympathicomometic
DE2413102C3 (de) * 1974-03-19 1980-09-11 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von l-(3,5-Dihydroxyphenyl)-t-hydroxy-2- eckige Klammer auf 1-methyl-2-(4-hydroxyphenyl)- äthyl] -aminoäthan

Also Published As

Publication number Publication date
FI792079A7 (fi) 1981-01-01
JPS559098A (en) 1980-01-22
GR72939B (es) 1984-01-16
RO77729A (ro) 1981-11-24
ES482154A1 (es) 1980-08-16
SU936804A3 (ru) 1982-06-15
DK269079A (da) 1980-02-01
PT69841A (en) 1979-07-01
EP0007205A1 (en) 1980-01-23
ATA463779A (de) 1982-01-15
AR225653A1 (es) 1982-04-15
BG31491A3 (bg) 1982-01-15
BG31376A3 (bg) 1981-12-15
BG31492A3 (bg) 1982-01-15
CA1145766A (en) 1983-05-03
PL118515B1 (en) 1981-10-31
IL57673A0 (en) 1979-10-31
DD145265A5 (de) 1980-12-03
ZA793298B (en) 1981-02-25
CS225850B2 (en) 1984-02-13
PL118755B1 (en) 1981-10-31
FR2430408A1 (fr) 1980-02-01
AU4849079A (en) 1980-01-10
ES8105264A1 (es) 1981-05-16
PL216812A1 (es) 1980-03-24
GB2029407A (en) 1980-03-19
ES490212A0 (es) 1981-05-16
ES8105265A1 (es) 1981-05-16
ES490213A0 (es) 1981-05-16
LU81455A1 (fr) 1979-10-30
PH15040A (en) 1982-05-20
BE877391A (fr) 1980-01-02
NZ190860A (en) 1982-05-25
PL117514B1 (en) 1981-08-31
AR221884A1 (es) 1981-03-31
ES490211A0 (es) 1981-05-16
BG31493A3 (bg) 1982-01-15

Similar Documents

Publication Publication Date Title
ES8105263A1 (es) Un procedimiento para la preparacion de fenetanolaminas
ES2152936T3 (es) Compuestos benzoheterociclicos.
ES8605492A1 (es) Procedimiento para la preparacion de 4,5-dihidro-3 (2h)-pi- ridazinonas sustituidas
ES2054679T3 (es) Vacunas.
IT7920255A0 (it) Procedimento per produrre idrogeno e ossigeno, nonche' cella elettrolitica per attuare tale procedimento.
JPS52108917A (en) Preparation of acrylic acid by vapor-phase catalytic oxidation of prop ylene
ES8104190A1 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
JPS54125617A (en) Ester interchange of carbonate
NO932147L (no) Antiallergiske forbindelser
MY101132A (en) An optically pure pipecoloxylidide hydrochloride and a process for its preparation
ES2001094A6 (es) Un procedimiento para la preparacion de un derivado de guanina
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
FR2439188A1 (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FR2370512A1 (fr) Composition catalytique et son application a la preparation d'acide acrylique et d'acide metacrylique
ES447424A1 (es) Procedimiento para la produccion continua de soluciones an- hidras de acido perpropionico.
DK552985A (da) Mercaptanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
ES8100263A1 (es) Procedimiento para preparar un derivado de acido 1-bencil-1,2,5,6-tetrahidropiridina-3-carboxilico
FR2405926A1 (fr) (asn2)-thymosine a1 et procede de preparation
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina
ES8403110A1 (es) Un procedimiento para la preparacion de pirbuterol.
FR2396014A1 (fr) Esters d'acides silylacetyleniques et leurs utilisations therapeutiques, notamment comme antibacteriens
JPS549247A (en) Preparation of menthone
ES8800925A1 (es) Un procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidinil)-1h-indazoles
NO851133L (no) Fremgangsmaate til fremstilling av hydrogenperoksyd